Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine effect on clopidogrel in ischemic heart disease
NCT01203696Phase 4Completed
- Sponsor
- Ruttonjee Hospital
- Start
- Jul 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amlodipine in ischemic heart disease (IHD), hypertension (HTN) and angina pectoris, sponsored by Ruttonjee Hospital. Primary endpoint: Platelet Reactivity Unit at 4 weeks. Started Jul 2010; status: completed.
02
Drugs
amlodipine
03
Conditions
ischemic heart disease (IHD)hypertension (HTN)angina pectoris
Beyond the preview
Go deeper on NCT01203696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203696.